A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1

被引:29
|
作者
Wang, YP
Friedl, W
Sengteller, M
Jungck, M
Filges, I
Propping, P
Mangold, E
机构
[1] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany
[2] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany
[3] Jiangsu Inst Canc Res, Nanjing, Peoples R China
关键词
HNPCC; multiplex PCR; mismatch repair genes; MMR; MSH2; MLH1; mutation analysis; mutation screening;
D O I
10.1002/humu.10042
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A method for detection of large genomic deletions in the MSH2 and MLH1 genes based on multiplex PCR and quantitative evaluation of PCR products is presented. All 35 exons of MSH2 and MLH1 were screened simultaneously in seven PCR reactions, each of them including primers for both genes. The method is reliable for uncovering large genomic deletions in patients suspected of HNPCC. With this method, six novel deletions were identified, two in MSH2: EX1_10del and EX1_16del (representing deletion of the entire MSH2 gene); and four in MLH1: EX1_10del in two unrelated patients, EX3_5del, and EX4del. The deletions were detected in 18 unrelated patients in whom no germline mutation had been identified by SSCP and DHPLC. These results indicate that our modified multiplex PCR assay is suited for the detection of large deletions both in die MSH2 and MLH1 gene and therefore represents an additional valuable tool for mutation screening in HNPCC families. Hum Mutat 19:279-286, 2002. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 50 条
  • [1] Hereditary nonpolyposis colorectal cancer:: Frequent occurrence of large genomic deletions in MSH2 and MLH1 genes
    Wang, YP
    Friedl, W
    Lamberti, C
    Jungck, M
    Mathiak, M
    Pagenstiecher, C
    Propping, P
    Mangold, E
    INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (05) : 636 - 641
  • [2] Cancer Risks for MLH1 and MSH2 Mutation Carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel D.
    Lindor, Noralane M.
    Macrae, Finlay A.
    Clendenning, Mark
    Antill, Yoland C.
    Thibodeau, Stephen N.
    Casey, Graham
    Gallinger, Steve
    Le Marchand, Loic
    Newcomb, Polly A.
    Haile, Robert W.
    Young, Graeme P.
    James, Paul A.
    Giles, Graham G.
    Gunawardena, Shanaka R.
    Leggett, Barbara A.
    Gattas, Michael
    Boussioutas, Alex
    Ahnen, Dennis J.
    Baron, John A.
    Parry, Susan
    Goldblatt, Jack
    Young, Joanne P.
    Hopper, John L.
    Jenkins, Mark A.
    HUMAN MUTATION, 2013, 34 (03) : 490 - 497
  • [3] Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach
    J J P Gille
    F B L Hogervorst
    G Pals
    J Th Wijnen
    R J van Schooten
    C J Dommering
    G A Meijer
    M E Craanen
    P M Nederlof
    D de Jong
    C J McElgunn
    J P Schouten
    F H Menko
    British Journal of Cancer, 2002, 87 : 892 - 897
  • [4] Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach
    Gille, JJP
    Hogervorst, FBL
    Pals, G
    Wijnen, JT
    van Schooten, RJ
    Dommering, CJ
    Meijer, GA
    Craanen, ME
    Nederlof, PM
    de Jong, D
    McElgunn, CJ
    Schouten, JP
    Menko, FH
    BRITISH JOURNAL OF CANCER, 2002, 87 (08) : 892 - 897
  • [5] Identification of Six Novel MSH2 and MLH1 Germline Mutations in HNPCC
    Krueger, Stefan
    Plaschke, Jens
    Jeske, Birgit
    Goergens, Heike
    Pistorius, Steffen R.
    Bier, Andrea
    Kreuz, Friedmar R.
    Theissig, Franz
    Aust, Daniela E.
    Saeger, Hans D.
    Schackert, Hans K.
    HUMAN MUTATION, 2003, 21 (04)
  • [6] Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer:: Identification of novel and recurrent deletions by MLPA
    Taylor, CE
    Charlton, RS
    Burn, J
    Sheridan, E
    Taylor, GR
    HUMAN MUTATION, 2003, 22 (06) : 428 - 433
  • [7] Expressional analysis of MLH1 and MSH2 in breast cancer
    Malik, Saima Shakil
    Masood, Nosheen
    Asif, Muhammad
    Ahmed, Parvez
    Shah, Zafar Ullah
    Khan, Jahangir Sarwar
    CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 97 - 105
  • [8] Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining
    Mangold, E
    Pagenstecher, C
    Friedl, W
    Fischer, HP
    Merkelbach-Bruse, S
    Ohlendorf, M
    Friedrichs, N
    Aretz, S
    Buettner, R
    Propping, P
    Mathiak, M
    JOURNAL OF PATHOLOGY, 2005, 207 (04): : 385 - 395
  • [9] Novel MLH1 and MSH2 Germline Mutations in the First HNPCC Families Identified in Slovakia
    Bartosova, Zdena
    Fridrichova, Ivana
    Bujalkova, Maria
    Wolf, Brigitte
    Ilencikova, Denisa
    Krizan, Peter
    Hlavcak, Peter
    Palaj, Julius
    Lukac, Ludovit
    Lukacova, Margita
    Boor, Andrej
    Haider, Ritva
    Jiricny, Josef
    Nystrom-Lahti, Minna
    Marra, Giancarlo
    HUMAN MUTATION, 2003, 21 (04)
  • [10] Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer
    Baert-Desurmont, Stephanie
    Buisine, Marie-Pierre
    Bessenay, Emilie
    Frerot, Stephanie
    Lovecchio, Tonio
    Martin, Cosette
    Olschwang, Sylviane
    Wang, Qing
    Frebourg, Thierry
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2007, 15 (03) : 383 - 386